Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70126 - 70150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CYP20A1	57404	downregulated	Silicon Dioxide results in decreased expression of CYP20A1 mRNA	2q33.2	A24196
Silicon dioxide	Approved	CYP24A1	1591	downregulated	Silicon Dioxide results in decreased expression of CYP24A1 mRNA	20q13.2	A24196
Silicon dioxide	Approved	CYP26A1	1592	upregulated	Silicon Dioxide analog results in increased expression of CYP26A1 mRNA	10q23.33	A24195
Silicon dioxide	Approved	CYP26B1	56603	downregulated	Silicon Dioxide analog results in decreased expression of CYP26B1 mRNA	2p13.2	A24195
Silicon dioxide	Approved	CYP26B1	56603	upregulated	Silicon Dioxide analog results in increased expression of CYP26B1 mRNA	2p13.2	A24194
Silicon dioxide	Approved	CYP2C18	1562	upregulated	Silicon Dioxide results in increased expression of CYP2C18 mRNA	10q23.33	A24196
Silicon dioxide	Approved	CYP2C8	1558	downregulated	Silicon Dioxide analog results in decreased expression of CYP2C8 mRNA	10q23.33	A24195
Silicon dioxide	Approved	CYP2C9	1559	downregulated	Silicon Dioxide analog results in decreased expression of CYP2C9 mRNA	10q23.33	A24195
Silicon dioxide	Approved	CYP2R1	120227	downregulated	Silicon Dioxide results in decreased expression of CYP2R1 mRNA	11p15.2	A24196
Silicon dioxide	Approved	CYP2S1	29785	downregulated	Silicon Dioxide analog results in decreased expression of CYP2S1 mRNA	19q13.2	A24195
Silicon dioxide	Approved	CYP3A4	1576	downregulated	Silicon Dioxide results in decreased expression of CYP3A4 mRNA	7q22.1	A24196
Silicon dioxide	Approved	CYP3A5	1577	downregulated	Silicon Dioxide analog results in decreased expression of CYP3A5 mRNA	7q22.1	A24195
Silicon dioxide	Approved	CYP3A5	1577	upregulated	Silicon Dioxide analog results in increased expression of CYP3A5 mRNA	7q22.1	A24194
Silicon dioxide	Approved	CYP3A7	1551	downregulated	Silicon Dioxide analog results in decreased expression of CYP3A7 mRNA	7q22.1	A24195
Silicon dioxide	Approved	CYP4B1	1580	downregulated	Silicon Dioxide results in decreased expression of CYP4B1 mRNA	1p33	A24197
Silicon dioxide	Approved	CYP4F11	57834	downregulated	Silicon Dioxide analog results in decreased expression of CYP4F11 mRNA	19p13.12	A24195
Silicon dioxide	Approved	CYP4F11	57834	upregulated	Silicon Dioxide results in increased expression of CYP4F11 mRNA	19p13.12	A24196
Silicon dioxide	Approved	CYP4F12	66002	downregulated	Silicon Dioxide analog results in decreased expression of CYP4F12 mRNA	19p13.12	A24195
Silicon dioxide	Approved	CYP4F2	8529	downregulated	Silicon Dioxide analog results in decreased expression of CYP4F2 mRNA	19p13.12	A24195
Silicon dioxide	Approved	CYP4F3	4051	downregulated	Silicon Dioxide results in decreased expression of CYP4F3 mRNA	19p13.12	A24196
Silicon dioxide	Approved	CYP4F8	11283	downregulated	Silicon Dioxide analog results in decreased expression of CYP4F8 mRNA	19p13.12	A24195
Silicon dioxide	Approved	CYP4X1	260293	upregulated	Silicon Dioxide analog results in increased expression of CYP4X1 mRNA	1p33	A24194
Silicon dioxide	Approved	CYR61	3491	upregulated	Silicon Dioxide analog results in increased expression of CYR61 mRNA	1p22.3	A24195
Silicon dioxide	Approved	CYR61	3491	upregulated	Silicon Dioxide results in increased expression of CYR61 mRNA	1p22.3	A24196
Silicon dioxide	Approved	CYTH4	27128	upregulated	Silicon Dioxide analog results in increased expression of CYTH4 mRNA	22q13.1	A24195

Displaying entries 70126 - 70150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability